Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer
¼°æ¿ø, ±Ç¿µ±â, ±èº´ÈÆ, ±èõÀÏ, ÀåÇõ¼ö, Ãֹ̼±, ¹ÚöÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
¼°æ¿ø ( Seo Kyung-Won )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±Ç¿µ±â ( Kwon Young-Kee )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±èº´ÈÆ ( Kim Byung-Hoon )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±èõÀÏ ( Kim Chun-Il )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÀåÇõ¼ö ( Chang Hyuk-Soo )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Ãֹ̼± ( Choe Mi-Sun )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹ÚöÈñ ( Park Choal-Hee )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0358320100510040239
Abstract
Purpose: The purpose of this study was to evaluate the correlation between the expression of claudins and prognostic factors in patients with prostate cancer.
Materials and Methods: The subjects of this study were 48 patients who had undergone surgery for prostate cancer. The Gleason score (6 or lower, 7 or higher), prostate-specific antigen (PSA) level, T stage, biochemical recurrence, local recurrence, and distant metastasis were compared according to the expression of claudin-1 and claudin-5 in prostate cancer.
Results: In the group with a low expression of claudin-1, the Gleason score was 7 points or higher in 18 cases (82%) and 6 points or lower in 4 cases (18%). In the group with a high expression of claudin-1, the Gleason score was 7 points or higher in 13 cases (50%) and 6 points or lower in 13 cases (50%). Thus, the low-expression group had more cases with a Gleason score of 7 or higher (p=0.022). The group with a low expression of claudin- 5 also had more cases with a Gleason score of 7 or higher (p=0.011). The mean PSA values in the groups with a low and high expression of claudin-1 were 9.6 ng/ml and 5.6 ng/ml, respectively (p=0.007). A low expression of claudin-5 was also associated with a high PSA value (p=0.002). There was no statistical difference in the expression of claudin-1 and claudin-5 by T stage, biochemical recurrence, local recurrence, or distant metastasis.
Conclusions: The low expression of claudin-1, claudin-5 was associated with a Gleason score of 7 or higher and a high PSA value in prostate cancer.
Å°¿öµå
Claudin 1;CLDN5 protein;Prostate-specific antigen;Prostatic neoplasms
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸